Impact of antithrombin III on hepatic and intestinal microcirculation in experimental liver cirrhosis and bowel inflammation: An in vivo analysis

Table 3 Results of intravital videomicroscopy: LEI in the liver and mesentery (mean±SD)

	Cirrhosis	Cirrhosis and IBD	ATIII treatment group (cirrhosis and IBD)	Controls
Adherent leukocytes (n/100 µm)
Liver	1.91±0.28a	5.40±1.65c	3.97±1.04e	0.5±0.5
Mesentery	2.54±1.19	5.24±1.23c	4.36±1.19	1.62±0.85
Rolling leukocytes (n/100 µm)
Liver	4.80±0.90a	5.32±1.29	3.40±0.54e	2.33±0.75
Mesentery	7.68±3.18	10.34±8.94	10.82±7.29	6.88±1.94

^aP<0.05 cirrhosis vs controls;

^cP<0.05 cirrhosis+IBD vs cirrhosis;

^eP<0.05 ATIII vs cirrhosis+IBD.